Factors affecting response of chemotherapy in women with ovarian cancer

被引：0
|
作者：
Lubin, J. [1 ]
Markowska, A. [2 ]
Knapp, P. [3 ]
机构：
[1] Clin Oncol Poznan, Dept Gynecol, Poznan, Poland
[2] Inst Gynecol & Obstet, Poznan, Poland
[3] Univ Hosp Bialystok, Dept Gynecol, Bialystok, Poland
来源：
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY | 2012年 / 33卷 / 06期
关键词：
Ovarian cancer; Chemotherapy; Factors affecting chemotherapy; MULTIDRUG-RESISTANCE GENE; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; PRODUCT P-GLYCOPROTEIN; PACLITAXEL RESISTANCE; PROTEIN LRP; E-CADHERIN; EXPRESSION; CLUSTERIN; MDR1; CYCLOOXYGENASE-2;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Chemotherapy plays an important role in the treatment of ovarian cancer. Patients' response to chemotherapy is determined by a variety of acknowledged factors, but one might expect that many of them are yet to be described. The aim of this paper was to present the most essential yet still to be generally assessed in clinical practice, factors, which include: E-cadhedrin, hypoxia inducible factor alpha, survivin, COX-2, clusterin, BRCA1 protein, TP53 protein, YY1 protein, multidrug resistance protein, and interleukin-8.
引用
下载
收藏
页码：644 / 647
页数：4
相关论文
共 50 条
  • [41] Factors affecting the outcome of laparoscopic ovarian drilling for polycystic ovarian syndrome in women with anovulatory infertility
    Li, TC
    Saravelos, H
    Chow, MS
    Chisabingo, R
    Cooke, ID
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1998, 105 (03): : 338 - 344
  • [42] Factors affecting quality of life in cancer patients undergoing chemotherapy
    Heydarnejad, M. S.
    Dehkordi, Hassanpour A.
    Dehkordi, Solati K.
    AFRICAN HEALTH SCIENCES, 2011, 11 (02) : 266 - 270
  • [43] Factors affecting the parentingstressand depressioninyoung women with breast cancer
    Shin, Yungil
    Kim, Harin
    Kim, Seonok
    Lee, Sae Byul
    Kim, Jisun
    Chung, Il Yong
    Ko, Beom Seok
    Lee, Jong Won
    Son, Byung Ho
    Ahn, Sei Hyun
    Kim, Hyo-Won
    Kim, Hee Jeong
    CANCER RESEARCH, 2022, 82 (04)
  • [44] Factors Affecting Risk of Mortality in Women With Vaginal Cancer
    Shah, Chirag A.
    Goff, Barbara A.
    Lowe, Kimberly
    Peters, William A., III
    Li, Christopher I.
    OBSTETRICS AND GYNECOLOGY, 2009, 113 (05): : 1038 - 1045
  • [45] The role of specialty training in the administration of chemotherapy for women with ovarian cancer
    Breed, C.
    Brennecke, A.
    Flink, D.
    Guntupalli, S.
    GYNECOLOGIC ONCOLOGY, 2017, 147 (01) : 213 - 214
  • [46] Intraperitoneal chemotherapy for women with ovarian cancer: Nursing care and considerations
    Potter, Kamala L.
    Held-Warmkessel, Jeanne
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2008, 12 (02) : 265 - 271
  • [47] Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy
    Sieja, K
    Talerczyk, M
    GYNECOLOGIC ONCOLOGY, 2005, 96 (02) : 559 - 560
  • [48] Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy
    Sieja, K
    Talerczyk, M
    GYNECOLOGIC ONCOLOGY, 2004, 93 (02) : 320 - 327
  • [49] Assessment of the effect of chemotherapy on ovarian function in women with breast cancer
    Anderson, Richard A.
    Cameron, David A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (12) : 1630 - 1631
  • [50] Frailty is a determinant of suboptimal chemotherapy in women with advanced ovarian cancer
    Narasimhulu, Deepa Maheswari
    McGree, Michaela E.
    Weaver, Amy L.
    Jatoi, Aminah
    LeBrasseur, Nathan K.
    Glaser, Gretchen E.
    Langstraat, Carrie L.
    Block, Matthew S.
    Kumar, Amanika
    GYNECOLOGIC ONCOLOGY, 2020, 158 (03) : 646 - 652
12345